Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft modelsSurendra R. Punganuru, Kalkunte S. Srivenugopal|Oncotarget|2018Cited by 22